Global Lurasidone Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Lurasidone market size was valued at US$ million in 2023. With growing demand in downstream market, the Lurasidone is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Lurasidone market. Lurasidone are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Lurasidone. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Lurasidone market.
Lurasidone, sold under the trade name Latuda among others, is an antipsychotic medication used to treat schizophrenia and bipolar disorder. In bipolar it may be used together with a mood stabilizer such as lithium or valproate. It is taken by mouth.
Common side effects include sleepiness, movement disorders, nausea, and diarrhea. Serious side effects may include the potentially permanent movement disorder tardive dyskinesia, as well as neuroleptic malignant syndrome, an increased risk of suicide, angioedema, and high blood sugar levels. In older people with psychosis as a result of dementia, it may increase the risk of dying.Use during pregnancy is of unclear safety. How it works is not clear but is believed to involve effects on dopamine and serotonin in the brain.
Key Features:
The report on Lurasidone market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Lurasidone market. It may include historical data, market segmentation by Type (e.g., 20mg/tablet, 40mg/tablet), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Lurasidone market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Lurasidone market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Lurasidone industry. This include advancements in Lurasidone technology, Lurasidone new entrants, Lurasidone new investment, and other innovations that are shaping the future of Lurasidone.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Lurasidone market. It includes factors influencing customer ' purchasing decisions, preferences for Lurasidone product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Lurasidone market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Lurasidone market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Lurasidone market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Lurasidone industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Lurasidone market.
Market Segmentation:
Lurasidone market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Lurasidone market?
What factors are driving Lurasidone market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Lurasidone market opportunities vary by end market size?
How does Lurasidone break out type, application?
According to our LPI (LP Information) latest study, the global Lurasidone market size was valued at US$ million in 2023. With growing demand in downstream market, the Lurasidone is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Lurasidone market. Lurasidone are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Lurasidone. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Lurasidone market.
Lurasidone, sold under the trade name Latuda among others, is an antipsychotic medication used to treat schizophrenia and bipolar disorder. In bipolar it may be used together with a mood stabilizer such as lithium or valproate. It is taken by mouth.
Common side effects include sleepiness, movement disorders, nausea, and diarrhea. Serious side effects may include the potentially permanent movement disorder tardive dyskinesia, as well as neuroleptic malignant syndrome, an increased risk of suicide, angioedema, and high blood sugar levels. In older people with psychosis as a result of dementia, it may increase the risk of dying.Use during pregnancy is of unclear safety. How it works is not clear but is believed to involve effects on dopamine and serotonin in the brain.
Key Features:
The report on Lurasidone market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Lurasidone market. It may include historical data, market segmentation by Type (e.g., 20mg/tablet, 40mg/tablet), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Lurasidone market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Lurasidone market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Lurasidone industry. This include advancements in Lurasidone technology, Lurasidone new entrants, Lurasidone new investment, and other innovations that are shaping the future of Lurasidone.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Lurasidone market. It includes factors influencing customer ' purchasing decisions, preferences for Lurasidone product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Lurasidone market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Lurasidone market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Lurasidone market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Lurasidone industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Lurasidone market.
Market Segmentation:
Lurasidone market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- 20mg/tablet
- 40mg/tablet
- 60mg/tablet
- 80mg/tablet
- 120mg/tablet
- Hospital
- Psychological Clinic
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Angelini Holding S.p.A.
- Sumitomo Dainippon Pharma Co., Ltd.
- RemedyRepack?Inc.
- Bushu Pharmaceutical, LTD.
- Zhejiang Hisun Pharmaceutical Co., Ltd.
- Healthcare Pharmaceuticals Limited
- Square Pharmaceuticals Ltd.
- Incepta Pharmaceuticals Ltd.
What is the 10-year outlook for the global Lurasidone market?
What factors are driving Lurasidone market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Lurasidone market opportunities vary by end market size?
How does Lurasidone break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Lurasidone Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Lurasidone by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Lurasidone by Country/Region, 2019, 2023 & 2030
2.2 Lurasidone Segment by Type
2.2.1 20mg/tablet
2.2.2 40mg/tablet
2.2.3 60mg/tablet
2.2.4 80mg/tablet
2.2.5 120mg/tablet
2.3 Lurasidone Sales by Type
2.3.1 Global Lurasidone Sales Market Share by Type (2019-2024)
2.3.2 Global Lurasidone Revenue and Market Share by Type (2019-2024)
2.3.3 Global Lurasidone Sale Price by Type (2019-2024)
2.4 Lurasidone Segment by Application
2.4.1 Hospital
2.4.2 Psychological Clinic
2.4.3 Others
2.5 Lurasidone Sales by Application
2.5.1 Global Lurasidone Sale Market Share by Application (2019-2024)
2.5.2 Global Lurasidone Revenue and Market Share by Application (2019-2024)
2.5.3 Global Lurasidone Sale Price by Application (2019-2024)
3 GLOBAL LURASIDONE BY COMPANY
3.1 Global Lurasidone Breakdown Data by Company
3.1.1 Global Lurasidone Annual Sales by Company (2019-2024)
3.1.2 Global Lurasidone Sales Market Share by Company (2019-2024)
3.2 Global Lurasidone Annual Revenue by Company (2019-2024)
3.2.1 Global Lurasidone Revenue by Company (2019-2024)
3.2.2 Global Lurasidone Revenue Market Share by Company (2019-2024)
3.3 Global Lurasidone Sale Price by Company
3.4 Key Manufacturers Lurasidone Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Lurasidone Product Location Distribution
3.4.2 Players Lurasidone Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR LURASIDONE BY GEOGRAPHIC REGION
4.1 World Historic Lurasidone Market Size by Geographic Region (2019-2024)
4.1.1 Global Lurasidone Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Lurasidone Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Lurasidone Market Size by Country/Region (2019-2024)
4.2.1 Global Lurasidone Annual Sales by Country/Region (2019-2024)
4.2.2 Global Lurasidone Annual Revenue by Country/Region (2019-2024)
4.3 Americas Lurasidone Sales Growth
4.4 APAC Lurasidone Sales Growth
4.5 Europe Lurasidone Sales Growth
4.6 Middle East & Africa Lurasidone Sales Growth
5 AMERICAS
5.1 Americas Lurasidone Sales by Country
5.1.1 Americas Lurasidone Sales by Country (2019-2024)
5.1.2 Americas Lurasidone Revenue by Country (2019-2024)
5.2 Americas Lurasidone Sales by Type
5.3 Americas Lurasidone Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Lurasidone Sales by Region
6.1.1 APAC Lurasidone Sales by Region (2019-2024)
6.1.2 APAC Lurasidone Revenue by Region (2019-2024)
6.2 APAC Lurasidone Sales by Type
6.3 APAC Lurasidone Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Lurasidone by Country
7.1.1 Europe Lurasidone Sales by Country (2019-2024)
7.1.2 Europe Lurasidone Revenue by Country (2019-2024)
7.2 Europe Lurasidone Sales by Type
7.3 Europe Lurasidone Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Lurasidone by Country
8.1.1 Middle East & Africa Lurasidone Sales by Country (2019-2024)
8.1.2 Middle East & Africa Lurasidone Revenue by Country (2019-2024)
8.2 Middle East & Africa Lurasidone Sales by Type
8.3 Middle East & Africa Lurasidone Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Lurasidone
10.3 Manufacturing Process Analysis of Lurasidone
10.4 Industry Chain Structure of Lurasidone
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Lurasidone Distributors
11.3 Lurasidone Customer
12 WORLD FORECAST REVIEW FOR LURASIDONE BY GEOGRAPHIC REGION
12.1 Global Lurasidone Market Size Forecast by Region
12.1.1 Global Lurasidone Forecast by Region (2025-2030)
12.1.2 Global Lurasidone Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Lurasidone Forecast by Type
12.7 Global Lurasidone Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Angelini Holding S.p.A.
13.1.1 Angelini Holding S.p.A. Company Information
13.1.2 Angelini Holding S.p.A. Lurasidone Product Portfolios and Specifications
13.1.3 Angelini Holding S.p.A. Lurasidone Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Angelini Holding S.p.A. Main Business Overview
13.1.5 Angelini Holding S.p.A. Latest Developments
13.2 Sumitomo Dainippon Pharma Co., Ltd.
13.2.1 Sumitomo Dainippon Pharma Co., Ltd. Company Information
13.2.2 Sumitomo Dainippon Pharma Co., Ltd. Lurasidone Product Portfolios and Specifications
13.2.3 Sumitomo Dainippon Pharma Co., Ltd. Lurasidone Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Sumitomo Dainippon Pharma Co., Ltd. Main Business Overview
13.2.5 Sumitomo Dainippon Pharma Co., Ltd. Latest Developments
13.3 RemedyRepack?Inc.
13.3.1 RemedyRepack?Inc. Company Information
13.3.2 RemedyRepack?Inc. Lurasidone Product Portfolios and Specifications
13.3.3 RemedyRepack?Inc. Lurasidone Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 RemedyRepack?Inc. Main Business Overview
13.3.5 RemedyRepack?Inc. Latest Developments
13.4 Bushu Pharmaceutical, LTD.
13.4.1 Bushu Pharmaceutical, LTD. Company Information
13.4.2 Bushu Pharmaceutical, LTD. Lurasidone Product Portfolios and Specifications
13.4.3 Bushu Pharmaceutical, LTD. Lurasidone Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Bushu Pharmaceutical, LTD. Main Business Overview
13.4.5 Bushu Pharmaceutical, LTD. Latest Developments
13.5 Zhejiang Hisun Pharmaceutical Co., Ltd.
13.5.1 Zhejiang Hisun Pharmaceutical Co., Ltd. Company Information
13.5.2 Zhejiang Hisun Pharmaceutical Co., Ltd. Lurasidone Product Portfolios and Specifications
13.5.3 Zhejiang Hisun Pharmaceutical Co., Ltd. Lurasidone Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Zhejiang Hisun Pharmaceutical Co., Ltd. Main Business Overview
13.5.5 Zhejiang Hisun Pharmaceutical Co., Ltd. Latest Developments
13.6 Healthcare Pharmaceuticals Limited
13.6.1 Healthcare Pharmaceuticals Limited Company Information
13.6.2 Healthcare Pharmaceuticals Limited Lurasidone Product Portfolios and Specifications
13.6.3 Healthcare Pharmaceuticals Limited Lurasidone Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Healthcare Pharmaceuticals Limited Main Business Overview
13.6.5 Healthcare Pharmaceuticals Limited Latest Developments
13.7 Square Pharmaceuticals Ltd.
13.7.1 Square Pharmaceuticals Ltd. Company Information
13.7.2 Square Pharmaceuticals Ltd. Lurasidone Product Portfolios and Specifications
13.7.3 Square Pharmaceuticals Ltd. Lurasidone Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Square Pharmaceuticals Ltd. Main Business Overview
13.7.5 Square Pharmaceuticals Ltd. Latest Developments
13.8 Incepta Pharmaceuticals Ltd.
13.8.1 Incepta Pharmaceuticals Ltd. Company Information
13.8.2 Incepta Pharmaceuticals Ltd. Lurasidone Product Portfolios and Specifications
13.8.3 Incepta Pharmaceuticals Ltd. Lurasidone Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Incepta Pharmaceuticals Ltd. Main Business Overview
13.8.5 Incepta Pharmaceuticals Ltd. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Lurasidone Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Lurasidone by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Lurasidone by Country/Region, 2019, 2023 & 2030
2.2 Lurasidone Segment by Type
2.2.1 20mg/tablet
2.2.2 40mg/tablet
2.2.3 60mg/tablet
2.2.4 80mg/tablet
2.2.5 120mg/tablet
2.3 Lurasidone Sales by Type
2.3.1 Global Lurasidone Sales Market Share by Type (2019-2024)
2.3.2 Global Lurasidone Revenue and Market Share by Type (2019-2024)
2.3.3 Global Lurasidone Sale Price by Type (2019-2024)
2.4 Lurasidone Segment by Application
2.4.1 Hospital
2.4.2 Psychological Clinic
2.4.3 Others
2.5 Lurasidone Sales by Application
2.5.1 Global Lurasidone Sale Market Share by Application (2019-2024)
2.5.2 Global Lurasidone Revenue and Market Share by Application (2019-2024)
2.5.3 Global Lurasidone Sale Price by Application (2019-2024)
3 GLOBAL LURASIDONE BY COMPANY
3.1 Global Lurasidone Breakdown Data by Company
3.1.1 Global Lurasidone Annual Sales by Company (2019-2024)
3.1.2 Global Lurasidone Sales Market Share by Company (2019-2024)
3.2 Global Lurasidone Annual Revenue by Company (2019-2024)
3.2.1 Global Lurasidone Revenue by Company (2019-2024)
3.2.2 Global Lurasidone Revenue Market Share by Company (2019-2024)
3.3 Global Lurasidone Sale Price by Company
3.4 Key Manufacturers Lurasidone Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Lurasidone Product Location Distribution
3.4.2 Players Lurasidone Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR LURASIDONE BY GEOGRAPHIC REGION
4.1 World Historic Lurasidone Market Size by Geographic Region (2019-2024)
4.1.1 Global Lurasidone Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Lurasidone Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Lurasidone Market Size by Country/Region (2019-2024)
4.2.1 Global Lurasidone Annual Sales by Country/Region (2019-2024)
4.2.2 Global Lurasidone Annual Revenue by Country/Region (2019-2024)
4.3 Americas Lurasidone Sales Growth
4.4 APAC Lurasidone Sales Growth
4.5 Europe Lurasidone Sales Growth
4.6 Middle East & Africa Lurasidone Sales Growth
5 AMERICAS
5.1 Americas Lurasidone Sales by Country
5.1.1 Americas Lurasidone Sales by Country (2019-2024)
5.1.2 Americas Lurasidone Revenue by Country (2019-2024)
5.2 Americas Lurasidone Sales by Type
5.3 Americas Lurasidone Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Lurasidone Sales by Region
6.1.1 APAC Lurasidone Sales by Region (2019-2024)
6.1.2 APAC Lurasidone Revenue by Region (2019-2024)
6.2 APAC Lurasidone Sales by Type
6.3 APAC Lurasidone Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Lurasidone by Country
7.1.1 Europe Lurasidone Sales by Country (2019-2024)
7.1.2 Europe Lurasidone Revenue by Country (2019-2024)
7.2 Europe Lurasidone Sales by Type
7.3 Europe Lurasidone Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Lurasidone by Country
8.1.1 Middle East & Africa Lurasidone Sales by Country (2019-2024)
8.1.2 Middle East & Africa Lurasidone Revenue by Country (2019-2024)
8.2 Middle East & Africa Lurasidone Sales by Type
8.3 Middle East & Africa Lurasidone Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Lurasidone
10.3 Manufacturing Process Analysis of Lurasidone
10.4 Industry Chain Structure of Lurasidone
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Lurasidone Distributors
11.3 Lurasidone Customer
12 WORLD FORECAST REVIEW FOR LURASIDONE BY GEOGRAPHIC REGION
12.1 Global Lurasidone Market Size Forecast by Region
12.1.1 Global Lurasidone Forecast by Region (2025-2030)
12.1.2 Global Lurasidone Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Lurasidone Forecast by Type
12.7 Global Lurasidone Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Angelini Holding S.p.A.
13.1.1 Angelini Holding S.p.A. Company Information
13.1.2 Angelini Holding S.p.A. Lurasidone Product Portfolios and Specifications
13.1.3 Angelini Holding S.p.A. Lurasidone Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Angelini Holding S.p.A. Main Business Overview
13.1.5 Angelini Holding S.p.A. Latest Developments
13.2 Sumitomo Dainippon Pharma Co., Ltd.
13.2.1 Sumitomo Dainippon Pharma Co., Ltd. Company Information
13.2.2 Sumitomo Dainippon Pharma Co., Ltd. Lurasidone Product Portfolios and Specifications
13.2.3 Sumitomo Dainippon Pharma Co., Ltd. Lurasidone Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Sumitomo Dainippon Pharma Co., Ltd. Main Business Overview
13.2.5 Sumitomo Dainippon Pharma Co., Ltd. Latest Developments
13.3 RemedyRepack?Inc.
13.3.1 RemedyRepack?Inc. Company Information
13.3.2 RemedyRepack?Inc. Lurasidone Product Portfolios and Specifications
13.3.3 RemedyRepack?Inc. Lurasidone Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 RemedyRepack?Inc. Main Business Overview
13.3.5 RemedyRepack?Inc. Latest Developments
13.4 Bushu Pharmaceutical, LTD.
13.4.1 Bushu Pharmaceutical, LTD. Company Information
13.4.2 Bushu Pharmaceutical, LTD. Lurasidone Product Portfolios and Specifications
13.4.3 Bushu Pharmaceutical, LTD. Lurasidone Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Bushu Pharmaceutical, LTD. Main Business Overview
13.4.5 Bushu Pharmaceutical, LTD. Latest Developments
13.5 Zhejiang Hisun Pharmaceutical Co., Ltd.
13.5.1 Zhejiang Hisun Pharmaceutical Co., Ltd. Company Information
13.5.2 Zhejiang Hisun Pharmaceutical Co., Ltd. Lurasidone Product Portfolios and Specifications
13.5.3 Zhejiang Hisun Pharmaceutical Co., Ltd. Lurasidone Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Zhejiang Hisun Pharmaceutical Co., Ltd. Main Business Overview
13.5.5 Zhejiang Hisun Pharmaceutical Co., Ltd. Latest Developments
13.6 Healthcare Pharmaceuticals Limited
13.6.1 Healthcare Pharmaceuticals Limited Company Information
13.6.2 Healthcare Pharmaceuticals Limited Lurasidone Product Portfolios and Specifications
13.6.3 Healthcare Pharmaceuticals Limited Lurasidone Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Healthcare Pharmaceuticals Limited Main Business Overview
13.6.5 Healthcare Pharmaceuticals Limited Latest Developments
13.7 Square Pharmaceuticals Ltd.
13.7.1 Square Pharmaceuticals Ltd. Company Information
13.7.2 Square Pharmaceuticals Ltd. Lurasidone Product Portfolios and Specifications
13.7.3 Square Pharmaceuticals Ltd. Lurasidone Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Square Pharmaceuticals Ltd. Main Business Overview
13.7.5 Square Pharmaceuticals Ltd. Latest Developments
13.8 Incepta Pharmaceuticals Ltd.
13.8.1 Incepta Pharmaceuticals Ltd. Company Information
13.8.2 Incepta Pharmaceuticals Ltd. Lurasidone Product Portfolios and Specifications
13.8.3 Incepta Pharmaceuticals Ltd. Lurasidone Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Incepta Pharmaceuticals Ltd. Main Business Overview
13.8.5 Incepta Pharmaceuticals Ltd. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Lurasidone Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Lurasidone Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of 20mg/tablet
Table 4. Major Players of 40mg/tablet
Table 5. Major Players of 60mg/tablet
Table 6. Major Players of 80mg/tablet
Table 7. Major Players of 120mg/tablet
Table 8. Global Lurasidone Sales by Type (2019-2024) & (K Units)
Table 9. Global Lurasidone Sales Market Share by Type (2019-2024)
Table 10. Global Lurasidone Revenue by Type (2019-2024) & ($ million)
Table 11. Global Lurasidone Revenue Market Share by Type (2019-2024)
Table 12. Global Lurasidone Sale Price by Type (2019-2024) & (US$/Unit)
Table 13. Global Lurasidone Sales by Application (2019-2024) & (K Units)
Table 14. Global Lurasidone Sales Market Share by Application (2019-2024)
Table 15. Global Lurasidone Revenue by Application (2019-2024)
Table 16. Global Lurasidone Revenue Market Share by Application (2019-2024)
Table 17. Global Lurasidone Sale Price by Application (2019-2024) & (US$/Unit)
Table 18. Global Lurasidone Sales by Company (2019-2024) & (K Units)
Table 19. Global Lurasidone Sales Market Share by Company (2019-2024)
Table 20. Global Lurasidone Revenue by Company (2019-2024) ($ Millions)
Table 21. Global Lurasidone Revenue Market Share by Company (2019-2024)
Table 22. Global Lurasidone Sale Price by Company (2019-2024) & (US$/Unit)
Table 23. Key Manufacturers Lurasidone Producing Area Distribution and Sales Area
Table 24. Players Lurasidone Products Offered
Table 25. Lurasidone Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Lurasidone Sales by Geographic Region (2019-2024) & (K Units)
Table 29. Global Lurasidone Sales Market Share Geographic Region (2019-2024)
Table 30. Global Lurasidone Revenue by Geographic Region (2019-2024) & ($ millions)
Table 31. Global Lurasidone Revenue Market Share by Geographic Region (2019-2024)
Table 32. Global Lurasidone Sales by Country/Region (2019-2024) & (K Units)
Table 33. Global Lurasidone Sales Market Share by Country/Region (2019-2024)
Table 34. Global Lurasidone Revenue by Country/Region (2019-2024) & ($ millions)
Table 35. Global Lurasidone Revenue Market Share by Country/Region (2019-2024)
Table 36. Americas Lurasidone Sales by Country (2019-2024) & (K Units)
Table 37. Americas Lurasidone Sales Market Share by Country (2019-2024)
Table 38. Americas Lurasidone Revenue by Country (2019-2024) & ($ Millions)
Table 39. Americas Lurasidone Revenue Market Share by Country (2019-2024)
Table 40. Americas Lurasidone Sales by Type (2019-2024) & (K Units)
Table 41. Americas Lurasidone Sales by Application (2019-2024) & (K Units)
Table 42. APAC Lurasidone Sales by Region (2019-2024) & (K Units)
Table 43. APAC Lurasidone Sales Market Share by Region (2019-2024)
Table 44. APAC Lurasidone Revenue by Region (2019-2024) & ($ Millions)
Table 45. APAC Lurasidone Revenue Market Share by Region (2019-2024)
Table 46. APAC Lurasidone Sales by Type (2019-2024) & (K Units)
Table 47. APAC Lurasidone Sales by Application (2019-2024) & (K Units)
Table 48. Europe Lurasidone Sales by Country (2019-2024) & (K Units)
Table 49. Europe Lurasidone Sales Market Share by Country (2019-2024)
Table 50. Europe Lurasidone Revenue by Country (2019-2024) & ($ Millions)
Table 51. Europe Lurasidone Revenue Market Share by Country (2019-2024)
Table 52. Europe Lurasidone Sales by Type (2019-2024) & (K Units)
Table 53. Europe Lurasidone Sales by Application (2019-2024) & (K Units)
Table 54. Middle East & Africa Lurasidone Sales by Country (2019-2024) & (K Units)
Table 55. Middle East & Africa Lurasidone Sales Market Share by Country (2019-2024)
Table 56. Middle East & Africa Lurasidone Revenue by Country (2019-2024) & ($ Millions)
Table 57. Middle East & Africa Lurasidone Revenue Market Share by Country (2019-2024)
Table 58. Middle East & Africa Lurasidone Sales by Type (2019-2024) & (K Units)
Table 59. Middle East & Africa Lurasidone Sales by Application (2019-2024) & (K Units)
Table 60. Key Market Drivers & Growth Opportunities of Lurasidone
Table 61. Key Market Challenges & Risks of Lurasidone
Table 62. Key Industry Trends of Lurasidone
Table 63. Lurasidone Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Lurasidone Distributors List
Table 66. Lurasidone Customer List
Table 67. Global Lurasidone Sales Forecast by Region (2025-2030) & (K Units)
Table 68. Global Lurasidone Revenue Forecast by Region (2025-2030) & ($ millions)
Table 69. Americas Lurasidone Sales Forecast by Country (2025-2030) & (K Units)
Table 70. Americas Lurasidone Revenue Forecast by Country (2025-2030) & ($ millions)
Table 71. APAC Lurasidone Sales Forecast by Region (2025-2030) & (K Units)
Table 72. APAC Lurasidone Revenue Forecast by Region (2025-2030) & ($ millions)
Table 73. Europe Lurasidone Sales Forecast by Country (2025-2030) & (K Units)
Table 74. Europe Lurasidone Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Middle East & Africa Lurasidone Sales Forecast by Country (2025-2030) & (K Units)
Table 76. Middle East & Africa Lurasidone Revenue Forecast by Country (2025-2030) & ($ millions)
Table 77. Global Lurasidone Sales Forecast by Type (2025-2030) & (K Units)
Table 78. Global Lurasidone Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 79. Global Lurasidone Sales Forecast by Application (2025-2030) & (K Units)
Table 80. Global Lurasidone Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 81. Angelini Holding S.p.A. Basic Information, Lurasidone Manufacturing Base, Sales Area and Its Competitors
Table 82. Angelini Holding S.p.A. Lurasidone Product Portfolios and Specifications
Table 83. Angelini Holding S.p.A. Lurasidone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 84. Angelini Holding S.p.A. Main Business
Table 85. Angelini Holding S.p.A. Latest Developments
Table 86. Sumitomo Dainippon Pharma Co., Ltd. Basic Information, Lurasidone Manufacturing Base, Sales Area and Its Competitors
Table 87. Sumitomo Dainippon Pharma Co., Ltd. Lurasidone Product Portfolios and Specifications
Table 88. Sumitomo Dainippon Pharma Co., Ltd. Lurasidone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 89. Sumitomo Dainippon Pharma Co., Ltd. Main Business
Table 90. Sumitomo Dainippon Pharma Co., Ltd. Latest Developments
Table 91. RemedyRepack?Inc. Basic Information, Lurasidone Manufacturing Base, Sales Area and Its Competitors
Table 92. RemedyRepack?Inc. Lurasidone Product Portfolios and Specifications
Table 93. RemedyRepack?Inc. Lurasidone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 94. RemedyRepack?Inc. Main Business
Table 95. RemedyRepack?Inc. Latest Developments
Table 96. Bushu Pharmaceutical, LTD. Basic Information, Lurasidone Manufacturing Base, Sales Area and Its Competitors
Table 97. Bushu Pharmaceutical, LTD. Lurasidone Product Portfolios and Specifications
Table 98. Bushu Pharmaceutical, LTD. Lurasidone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 99. Bushu Pharmaceutical, LTD. Main Business
Table 100. Bushu Pharmaceutical, LTD. Latest Developments
Table 101. Zhejiang Hisun Pharmaceutical Co., Ltd. Basic Information, Lurasidone Manufacturing Base, Sales Area and Its Competitors
Table 102. Zhejiang Hisun Pharmaceutical Co., Ltd. Lurasidone Product Portfolios and Specifications
Table 103. Zhejiang Hisun Pharmaceutical Co., Ltd. Lurasidone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 104. Zhejiang Hisun Pharmaceutical Co., Ltd. Main Business
Table 105. Zhejiang Hisun Pharmaceutical Co., Ltd. Latest Developments
Table 106. Healthcare Pharmaceuticals Limited Basic Information, Lurasidone Manufacturing Base, Sales Area and Its Competitors
Table 107. Healthcare Pharmaceuticals Limited Lurasidone Product Portfolios and Specifications
Table 108. Healthcare Pharmaceuticals Limited Lurasidone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 109. Healthcare Pharmaceuticals Limited Main Business
Table 110. Healthcare Pharmaceuticals Limited Latest Developments
Table 111. Square Pharmaceuticals Ltd. Basic Information, Lurasidone Manufacturing Base, Sales Area and Its Competitors
Table 112. Square Pharmaceuticals Ltd. Lurasidone Product Portfolios and Specifications
Table 113. Square Pharmaceuticals Ltd. Lurasidone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 114. Square Pharmaceuticals Ltd. Main Business
Table 115. Square Pharmaceuticals Ltd. Latest Developments
Table 116. Incepta Pharmaceuticals Ltd. Basic Information, Lurasidone Manufacturing Base, Sales Area and Its Competitors
Table 117. Incepta Pharmaceuticals Ltd. Lurasidone Product Portfolios and Specifications
Table 118. Incepta Pharmaceuticals Ltd. Lurasidone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 119. Incepta Pharmaceuticals Ltd. Main Business
Table 120. Incepta Pharmaceuticals Ltd. Latest Developments
Table 1. Lurasidone Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Lurasidone Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of 20mg/tablet
Table 4. Major Players of 40mg/tablet
Table 5. Major Players of 60mg/tablet
Table 6. Major Players of 80mg/tablet
Table 7. Major Players of 120mg/tablet
Table 8. Global Lurasidone Sales by Type (2019-2024) & (K Units)
Table 9. Global Lurasidone Sales Market Share by Type (2019-2024)
Table 10. Global Lurasidone Revenue by Type (2019-2024) & ($ million)
Table 11. Global Lurasidone Revenue Market Share by Type (2019-2024)
Table 12. Global Lurasidone Sale Price by Type (2019-2024) & (US$/Unit)
Table 13. Global Lurasidone Sales by Application (2019-2024) & (K Units)
Table 14. Global Lurasidone Sales Market Share by Application (2019-2024)
Table 15. Global Lurasidone Revenue by Application (2019-2024)
Table 16. Global Lurasidone Revenue Market Share by Application (2019-2024)
Table 17. Global Lurasidone Sale Price by Application (2019-2024) & (US$/Unit)
Table 18. Global Lurasidone Sales by Company (2019-2024) & (K Units)
Table 19. Global Lurasidone Sales Market Share by Company (2019-2024)
Table 20. Global Lurasidone Revenue by Company (2019-2024) ($ Millions)
Table 21. Global Lurasidone Revenue Market Share by Company (2019-2024)
Table 22. Global Lurasidone Sale Price by Company (2019-2024) & (US$/Unit)
Table 23. Key Manufacturers Lurasidone Producing Area Distribution and Sales Area
Table 24. Players Lurasidone Products Offered
Table 25. Lurasidone Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Lurasidone Sales by Geographic Region (2019-2024) & (K Units)
Table 29. Global Lurasidone Sales Market Share Geographic Region (2019-2024)
Table 30. Global Lurasidone Revenue by Geographic Region (2019-2024) & ($ millions)
Table 31. Global Lurasidone Revenue Market Share by Geographic Region (2019-2024)
Table 32. Global Lurasidone Sales by Country/Region (2019-2024) & (K Units)
Table 33. Global Lurasidone Sales Market Share by Country/Region (2019-2024)
Table 34. Global Lurasidone Revenue by Country/Region (2019-2024) & ($ millions)
Table 35. Global Lurasidone Revenue Market Share by Country/Region (2019-2024)
Table 36. Americas Lurasidone Sales by Country (2019-2024) & (K Units)
Table 37. Americas Lurasidone Sales Market Share by Country (2019-2024)
Table 38. Americas Lurasidone Revenue by Country (2019-2024) & ($ Millions)
Table 39. Americas Lurasidone Revenue Market Share by Country (2019-2024)
Table 40. Americas Lurasidone Sales by Type (2019-2024) & (K Units)
Table 41. Americas Lurasidone Sales by Application (2019-2024) & (K Units)
Table 42. APAC Lurasidone Sales by Region (2019-2024) & (K Units)
Table 43. APAC Lurasidone Sales Market Share by Region (2019-2024)
Table 44. APAC Lurasidone Revenue by Region (2019-2024) & ($ Millions)
Table 45. APAC Lurasidone Revenue Market Share by Region (2019-2024)
Table 46. APAC Lurasidone Sales by Type (2019-2024) & (K Units)
Table 47. APAC Lurasidone Sales by Application (2019-2024) & (K Units)
Table 48. Europe Lurasidone Sales by Country (2019-2024) & (K Units)
Table 49. Europe Lurasidone Sales Market Share by Country (2019-2024)
Table 50. Europe Lurasidone Revenue by Country (2019-2024) & ($ Millions)
Table 51. Europe Lurasidone Revenue Market Share by Country (2019-2024)
Table 52. Europe Lurasidone Sales by Type (2019-2024) & (K Units)
Table 53. Europe Lurasidone Sales by Application (2019-2024) & (K Units)
Table 54. Middle East & Africa Lurasidone Sales by Country (2019-2024) & (K Units)
Table 55. Middle East & Africa Lurasidone Sales Market Share by Country (2019-2024)
Table 56. Middle East & Africa Lurasidone Revenue by Country (2019-2024) & ($ Millions)
Table 57. Middle East & Africa Lurasidone Revenue Market Share by Country (2019-2024)
Table 58. Middle East & Africa Lurasidone Sales by Type (2019-2024) & (K Units)
Table 59. Middle East & Africa Lurasidone Sales by Application (2019-2024) & (K Units)
Table 60. Key Market Drivers & Growth Opportunities of Lurasidone
Table 61. Key Market Challenges & Risks of Lurasidone
Table 62. Key Industry Trends of Lurasidone
Table 63. Lurasidone Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Lurasidone Distributors List
Table 66. Lurasidone Customer List
Table 67. Global Lurasidone Sales Forecast by Region (2025-2030) & (K Units)
Table 68. Global Lurasidone Revenue Forecast by Region (2025-2030) & ($ millions)
Table 69. Americas Lurasidone Sales Forecast by Country (2025-2030) & (K Units)
Table 70. Americas Lurasidone Revenue Forecast by Country (2025-2030) & ($ millions)
Table 71. APAC Lurasidone Sales Forecast by Region (2025-2030) & (K Units)
Table 72. APAC Lurasidone Revenue Forecast by Region (2025-2030) & ($ millions)
Table 73. Europe Lurasidone Sales Forecast by Country (2025-2030) & (K Units)
Table 74. Europe Lurasidone Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Middle East & Africa Lurasidone Sales Forecast by Country (2025-2030) & (K Units)
Table 76. Middle East & Africa Lurasidone Revenue Forecast by Country (2025-2030) & ($ millions)
Table 77. Global Lurasidone Sales Forecast by Type (2025-2030) & (K Units)
Table 78. Global Lurasidone Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 79. Global Lurasidone Sales Forecast by Application (2025-2030) & (K Units)
Table 80. Global Lurasidone Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 81. Angelini Holding S.p.A. Basic Information, Lurasidone Manufacturing Base, Sales Area and Its Competitors
Table 82. Angelini Holding S.p.A. Lurasidone Product Portfolios and Specifications
Table 83. Angelini Holding S.p.A. Lurasidone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 84. Angelini Holding S.p.A. Main Business
Table 85. Angelini Holding S.p.A. Latest Developments
Table 86. Sumitomo Dainippon Pharma Co., Ltd. Basic Information, Lurasidone Manufacturing Base, Sales Area and Its Competitors
Table 87. Sumitomo Dainippon Pharma Co., Ltd. Lurasidone Product Portfolios and Specifications
Table 88. Sumitomo Dainippon Pharma Co., Ltd. Lurasidone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 89. Sumitomo Dainippon Pharma Co., Ltd. Main Business
Table 90. Sumitomo Dainippon Pharma Co., Ltd. Latest Developments
Table 91. RemedyRepack?Inc. Basic Information, Lurasidone Manufacturing Base, Sales Area and Its Competitors
Table 92. RemedyRepack?Inc. Lurasidone Product Portfolios and Specifications
Table 93. RemedyRepack?Inc. Lurasidone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 94. RemedyRepack?Inc. Main Business
Table 95. RemedyRepack?Inc. Latest Developments
Table 96. Bushu Pharmaceutical, LTD. Basic Information, Lurasidone Manufacturing Base, Sales Area and Its Competitors
Table 97. Bushu Pharmaceutical, LTD. Lurasidone Product Portfolios and Specifications
Table 98. Bushu Pharmaceutical, LTD. Lurasidone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 99. Bushu Pharmaceutical, LTD. Main Business
Table 100. Bushu Pharmaceutical, LTD. Latest Developments
Table 101. Zhejiang Hisun Pharmaceutical Co., Ltd. Basic Information, Lurasidone Manufacturing Base, Sales Area and Its Competitors
Table 102. Zhejiang Hisun Pharmaceutical Co., Ltd. Lurasidone Product Portfolios and Specifications
Table 103. Zhejiang Hisun Pharmaceutical Co., Ltd. Lurasidone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 104. Zhejiang Hisun Pharmaceutical Co., Ltd. Main Business
Table 105. Zhejiang Hisun Pharmaceutical Co., Ltd. Latest Developments
Table 106. Healthcare Pharmaceuticals Limited Basic Information, Lurasidone Manufacturing Base, Sales Area and Its Competitors
Table 107. Healthcare Pharmaceuticals Limited Lurasidone Product Portfolios and Specifications
Table 108. Healthcare Pharmaceuticals Limited Lurasidone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 109. Healthcare Pharmaceuticals Limited Main Business
Table 110. Healthcare Pharmaceuticals Limited Latest Developments
Table 111. Square Pharmaceuticals Ltd. Basic Information, Lurasidone Manufacturing Base, Sales Area and Its Competitors
Table 112. Square Pharmaceuticals Ltd. Lurasidone Product Portfolios and Specifications
Table 113. Square Pharmaceuticals Ltd. Lurasidone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 114. Square Pharmaceuticals Ltd. Main Business
Table 115. Square Pharmaceuticals Ltd. Latest Developments
Table 116. Incepta Pharmaceuticals Ltd. Basic Information, Lurasidone Manufacturing Base, Sales Area and Its Competitors
Table 117. Incepta Pharmaceuticals Ltd. Lurasidone Product Portfolios and Specifications
Table 118. Incepta Pharmaceuticals Ltd. Lurasidone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 119. Incepta Pharmaceuticals Ltd. Main Business
Table 120. Incepta Pharmaceuticals Ltd. Latest Developments
LIST OF FIGURES
Figure 1. Picture of Lurasidone
Figure 2. Lurasidone Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Lurasidone Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Lurasidone Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Lurasidone Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of 20mg/tablet
Figure 10. Product Picture of 40mg/tablet
Figure 11. Product Picture of 60mg/tablet
Figure 12. Product Picture of 80mg/tablet
Figure 13. Product Picture of 120mg/tablet
Figure 14. Global Lurasidone Sales Market Share by Type in 2023
Figure 15. Global Lurasidone Revenue Market Share by Type (2019-2024)
Figure 16. Lurasidone Consumed in Hospital
Figure 17. Global Lurasidone Market: Hospital (2019-2024) & (K Units)
Figure 18. Lurasidone Consumed in Psychological Clinic
Figure 19. Global Lurasidone Market: Psychological Clinic (2019-2024) & (K Units)
Figure 20. Lurasidone Consumed in Others
Figure 21. Global Lurasidone Market: Others (2019-2024) & (K Units)
Figure 22. Global Lurasidone Sales Market Share by Application (2023)
Figure 23. Global Lurasidone Revenue Market Share by Application in 2023
Figure 24. Lurasidone Sales Market by Company in 2023 (K Units)
Figure 25. Global Lurasidone Sales Market Share by Company in 2023
Figure 26. Lurasidone Revenue Market by Company in 2023 ($ Million)
Figure 27. Global Lurasidone Revenue Market Share by Company in 2023
Figure 28. Global Lurasidone Sales Market Share by Geographic Region (2019-2024)
Figure 29. Global Lurasidone Revenue Market Share by Geographic Region in 2023
Figure 30. Americas Lurasidone Sales 2019-2024 (K Units)
Figure 31. Americas Lurasidone Revenue 2019-2024 ($ Millions)
Figure 32. APAC Lurasidone Sales 2019-2024 (K Units)
Figure 33. APAC Lurasidone Revenue 2019-2024 ($ Millions)
Figure 34. Europe Lurasidone Sales 2019-2024 (K Units)
Figure 35. Europe Lurasidone Revenue 2019-2024 ($ Millions)
Figure 36. Middle East & Africa Lurasidone Sales 2019-2024 (K Units)
Figure 37. Middle East & Africa Lurasidone Revenue 2019-2024 ($ Millions)
Figure 38. Americas Lurasidone Sales Market Share by Country in 2023
Figure 39. Americas Lurasidone Revenue Market Share by Country in 2023
Figure 40. Americas Lurasidone Sales Market Share by Type (2019-2024)
Figure 41. Americas Lurasidone Sales Market Share by Application (2019-2024)
Figure 42. United States Lurasidone Revenue Growth 2019-2024 ($ Millions)
Figure 43. Canada Lurasidone Revenue Growth 2019-2024 ($ Millions)
Figure 44. Mexico Lurasidone Revenue Growth 2019-2024 ($ Millions)
Figure 45. Brazil Lurasidone Revenue Growth 2019-2024 ($ Millions)
Figure 46. APAC Lurasidone Sales Market Share by Region in 2023
Figure 47. APAC Lurasidone Revenue Market Share by Regions in 2023
Figure 48. APAC Lurasidone Sales Market Share by Type (2019-2024)
Figure 49. APAC Lurasidone Sales Market Share by Application (2019-2024)
Figure 50. China Lurasidone Revenue Growth 2019-2024 ($ Millions)
Figure 51. Japan Lurasidone Revenue Growth 2019-2024 ($ Millions)
Figure 52. South Korea Lurasidone Revenue Growth 2019-2024 ($ Millions)
Figure 53. Southeast Asia Lurasidone Revenue Growth 2019-2024 ($ Millions)
Figure 54. India Lurasidone Revenue Growth 2019-2024 ($ Millions)
Figure 55. Australia Lurasidone Revenue Growth 2019-2024 ($ Millions)
Figure 56. China Taiwan Lurasidone Revenue Growth 2019-2024 ($ Millions)
Figure 57. Europe Lurasidone Sales Market Share by Country in 2023
Figure 58. Europe Lurasidone Revenue Market Share by Country in 2023
Figure 59. Europe Lurasidone Sales Market Share by Type (2019-2024)
Figure 60. Europe Lurasidone Sales Market Share by Application (2019-2024)
Figure 61. Germany Lurasidone Revenue Growth 2019-2024 ($ Millions)
Figure 62. France Lurasidone Revenue Growth 2019-2024 ($ Millions)
Figure 63. UK Lurasidone Revenue Growth 2019-2024 ($ Millions)
Figure 64. Italy Lurasidone Revenue Growth 2019-2024 ($ Millions)
Figure 65. Russia Lurasidone Revenue Growth 2019-2024 ($ Millions)
Figure 66. Middle East & Africa Lurasidone Sales Market Share by Country in 2023
Figure 67. Middle East & Africa Lurasidone Revenue Market Share by Country in 2023
Figure 68. Middle East & Africa Lurasidone Sales Market Share by Type (2019-2024)
Figure 69. Middle East & Africa Lurasidone Sales Market Share by Application (2019-2024)
Figure 70. Egypt Lurasidone Revenue Growth 2019-2024 ($ Millions)
Figure 71. South Africa Lurasidone Revenue Growth 2019-2024 ($ Millions)
Figure 72. Israel Lurasidone Revenue Growth 2019-2024 ($ Millions)
Figure 73. Turkey Lurasidone Revenue Growth 2019-2024 ($ Millions)
Figure 74. GCC Country Lurasidone Revenue Growth 2019-2024 ($ Millions)
Figure 75. Manufacturing Cost Structure Analysis of Lurasidone in 2023
Figure 76. Manufacturing Process Analysis of Lurasidone
Figure 77. Industry Chain Structure of Lurasidone
Figure 78. Channels of Distribution
Figure 79. Global Lurasidone Sales Market Forecast by Region (2025-2030)
Figure 80. Global Lurasidone Revenue Market Share Forecast by Region (2025-2030)
Figure 81. Global Lurasidone Sales Market Share Forecast by Type (2025-2030)
Figure 82. Global Lurasidone Revenue Market Share Forecast by Type (2025-2030)
Figure 83. Global Lurasidone Sales Market Share Forecast by Application (2025-2030)
Figure 84. Global Lurasidone Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Lurasidone
Figure 2. Lurasidone Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Lurasidone Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Lurasidone Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Lurasidone Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of 20mg/tablet
Figure 10. Product Picture of 40mg/tablet
Figure 11. Product Picture of 60mg/tablet
Figure 12. Product Picture of 80mg/tablet
Figure 13. Product Picture of 120mg/tablet
Figure 14. Global Lurasidone Sales Market Share by Type in 2023
Figure 15. Global Lurasidone Revenue Market Share by Type (2019-2024)
Figure 16. Lurasidone Consumed in Hospital
Figure 17. Global Lurasidone Market: Hospital (2019-2024) & (K Units)
Figure 18. Lurasidone Consumed in Psychological Clinic
Figure 19. Global Lurasidone Market: Psychological Clinic (2019-2024) & (K Units)
Figure 20. Lurasidone Consumed in Others
Figure 21. Global Lurasidone Market: Others (2019-2024) & (K Units)
Figure 22. Global Lurasidone Sales Market Share by Application (2023)
Figure 23. Global Lurasidone Revenue Market Share by Application in 2023
Figure 24. Lurasidone Sales Market by Company in 2023 (K Units)
Figure 25. Global Lurasidone Sales Market Share by Company in 2023
Figure 26. Lurasidone Revenue Market by Company in 2023 ($ Million)
Figure 27. Global Lurasidone Revenue Market Share by Company in 2023
Figure 28. Global Lurasidone Sales Market Share by Geographic Region (2019-2024)
Figure 29. Global Lurasidone Revenue Market Share by Geographic Region in 2023
Figure 30. Americas Lurasidone Sales 2019-2024 (K Units)
Figure 31. Americas Lurasidone Revenue 2019-2024 ($ Millions)
Figure 32. APAC Lurasidone Sales 2019-2024 (K Units)
Figure 33. APAC Lurasidone Revenue 2019-2024 ($ Millions)
Figure 34. Europe Lurasidone Sales 2019-2024 (K Units)
Figure 35. Europe Lurasidone Revenue 2019-2024 ($ Millions)
Figure 36. Middle East & Africa Lurasidone Sales 2019-2024 (K Units)
Figure 37. Middle East & Africa Lurasidone Revenue 2019-2024 ($ Millions)
Figure 38. Americas Lurasidone Sales Market Share by Country in 2023
Figure 39. Americas Lurasidone Revenue Market Share by Country in 2023
Figure 40. Americas Lurasidone Sales Market Share by Type (2019-2024)
Figure 41. Americas Lurasidone Sales Market Share by Application (2019-2024)
Figure 42. United States Lurasidone Revenue Growth 2019-2024 ($ Millions)
Figure 43. Canada Lurasidone Revenue Growth 2019-2024 ($ Millions)
Figure 44. Mexico Lurasidone Revenue Growth 2019-2024 ($ Millions)
Figure 45. Brazil Lurasidone Revenue Growth 2019-2024 ($ Millions)
Figure 46. APAC Lurasidone Sales Market Share by Region in 2023
Figure 47. APAC Lurasidone Revenue Market Share by Regions in 2023
Figure 48. APAC Lurasidone Sales Market Share by Type (2019-2024)
Figure 49. APAC Lurasidone Sales Market Share by Application (2019-2024)
Figure 50. China Lurasidone Revenue Growth 2019-2024 ($ Millions)
Figure 51. Japan Lurasidone Revenue Growth 2019-2024 ($ Millions)
Figure 52. South Korea Lurasidone Revenue Growth 2019-2024 ($ Millions)
Figure 53. Southeast Asia Lurasidone Revenue Growth 2019-2024 ($ Millions)
Figure 54. India Lurasidone Revenue Growth 2019-2024 ($ Millions)
Figure 55. Australia Lurasidone Revenue Growth 2019-2024 ($ Millions)
Figure 56. China Taiwan Lurasidone Revenue Growth 2019-2024 ($ Millions)
Figure 57. Europe Lurasidone Sales Market Share by Country in 2023
Figure 58. Europe Lurasidone Revenue Market Share by Country in 2023
Figure 59. Europe Lurasidone Sales Market Share by Type (2019-2024)
Figure 60. Europe Lurasidone Sales Market Share by Application (2019-2024)
Figure 61. Germany Lurasidone Revenue Growth 2019-2024 ($ Millions)
Figure 62. France Lurasidone Revenue Growth 2019-2024 ($ Millions)
Figure 63. UK Lurasidone Revenue Growth 2019-2024 ($ Millions)
Figure 64. Italy Lurasidone Revenue Growth 2019-2024 ($ Millions)
Figure 65. Russia Lurasidone Revenue Growth 2019-2024 ($ Millions)
Figure 66. Middle East & Africa Lurasidone Sales Market Share by Country in 2023
Figure 67. Middle East & Africa Lurasidone Revenue Market Share by Country in 2023
Figure 68. Middle East & Africa Lurasidone Sales Market Share by Type (2019-2024)
Figure 69. Middle East & Africa Lurasidone Sales Market Share by Application (2019-2024)
Figure 70. Egypt Lurasidone Revenue Growth 2019-2024 ($ Millions)
Figure 71. South Africa Lurasidone Revenue Growth 2019-2024 ($ Millions)
Figure 72. Israel Lurasidone Revenue Growth 2019-2024 ($ Millions)
Figure 73. Turkey Lurasidone Revenue Growth 2019-2024 ($ Millions)
Figure 74. GCC Country Lurasidone Revenue Growth 2019-2024 ($ Millions)
Figure 75. Manufacturing Cost Structure Analysis of Lurasidone in 2023
Figure 76. Manufacturing Process Analysis of Lurasidone
Figure 77. Industry Chain Structure of Lurasidone
Figure 78. Channels of Distribution
Figure 79. Global Lurasidone Sales Market Forecast by Region (2025-2030)
Figure 80. Global Lurasidone Revenue Market Share Forecast by Region (2025-2030)
Figure 81. Global Lurasidone Sales Market Share Forecast by Type (2025-2030)
Figure 82. Global Lurasidone Revenue Market Share Forecast by Type (2025-2030)
Figure 83. Global Lurasidone Sales Market Share Forecast by Application (2025-2030)
Figure 84. Global Lurasidone Revenue Market Share Forecast by Application (2025-2030)
More Publications
Global Impulse Wave Diagnostic Ultrasound Devices Market Growth 2023-2029
US$ 3,660.00
February 2023
102 pages
Global Medical Stretch Bandages Market Growth 2024-2030
US$ 3,660.00
December 2024
112 pages
Global Rhematoid Arthritis Drugs Market Growth 2024-2030
US$ 3,660.00
March 2024
110 pages
Global Oxymeter Market Growth 2024-2030
US$ 3,660.00
March 2024
115 pages
